Treatment/Assay | AO/EB (%) | DiOC6(3)High/Low (%) |
---|---|---|
Untreated | < 1 ± 0 | > 99 ± 0 |
VK3 (10 μM) | 35 ± 3 | 63 ± 2 |
VC (10 mM) | 26 ± 2 | 73 ± 3 |
VK3 (10 μM) + VC (10 mM) | 58 ± 3 | 63 ± 3 |
PDTC (10 nM) | < 1 ± 0 | > 99 ± 0 |
PDTC (10 nM) + VK3 (10 μM) | 3 ± 1a | 97 ± 1a |
PDTC (10 nM) + VC (10 mM) | 8 ± 2b | 90 ± 2b |
PDTC (10 nM) + VK3 (10 μM) + VC (10 mM) | 13 ± 2c | 80 ± 3c |
PFT (50 nM) | < 1 ± 0 | > 99 ± 0 |
PFT (50 nM) + VK3 (10 μM) | 4 ± 1a | 98 ± 1a |
PFT (50 nM) + VC (10 mM) | 3 ± 1b | 95 ± 2b |
PFT (50 nM) + VK3 (10 μM) + VC (10 mM) | 6 ± 2c | 92 ± 3c |
SP600125 (1 μM) | 2 ± 1 | 97 ± 2 |
SP600125 (1 μM) + VK3 (10 μM) | 6 ± 2a | 90 ± 3a |
SP600125 (1 μM) + VC (10 mM) | 8 ± 2b | 89 ± 3b |
SP600125 (1 μM) + VK3 (10 μM) + VC (10 mM) | 20 ± 2c | 80 ± 3c |
NSCI (10 μM) | < 1 ± 0 | > 99 ± 0 |
NSCI (10 μM) + VK3 (10 μM) | 3 ± 1a | 95 ± 2a |
NSCI (10 μM) + VC (10 mM) | 8 ± 1b | 95 ± 3b |
NSCI (10 μM) + VK3 (10 μM) + VC (10 mM) | 8 ± 1c | 95 ± 3c |